ExodusPoint Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-281,477	Closed	-$768K	–	1824
2025 Q4	$768K	Buy	281,477 +239,354	+568%	+$554K	0.01%	1081
2025 Q3	$91.4K	Buy	+42,123	New	+$99.5K	﹤0.01%	1431
2025 Q2	–	Sell	-1,170,745	Closed	-$3.9M	–	1712
2025 Q1	$3.9M	Buy	+1,170,745	New	+$6.04M	0.05%	496
2023 Q4	–	Sell	-98,663	Closed	-$449K	–	1754
2023 Q3	$449K	Sell	98,663 -351,237	-78%	-$2.29M	0.01%	1282
2023 Q2	$3.17M	Buy	+449,900	New	+$3.22M	0.04%	621
2023 Q1	–	Sell	-253,733	Closed	-$1.62M	–	1939
2022 Q4	$1.62M	Buy	253,733 +183,354	+261%	+$1.43M	0.03%	740
2022 Q3	$674K	Sell	70,379 -29,400	-29%	-$339K	0.01%	1265
2022 Q2	$1.1M	Sell	99,779 -38,576	-28%	-$506K	0.02%	1039
2022 Q1	$2.3M	Buy	138,355 +122,876	+794%	+$1.9M	0.03%	711
2021 Q4	$295K	Sell	15,479 -14,275	-48%	-$314K	﹤0.01%	1665
2021 Q3	$734K	Sell	29,754 -22,898	-43%	-$540K	0.01%	1184
2021 Q2	$1.37M	Buy	+52,652	New	+$1.37M	0.02%	844
2021 Q1	–	Sell	-45,671	Closed	-$2.12M	–	2347
2020 Q4	$2.12M	Buy	45,671 +30,495	+201%	+$1.21M	0.03%	524
2020 Q3	$500K	Sell	15,176 -71,744	-83%	-$2.2M	0.01%	1018
2020 Q2	$2.39M	Buy	+86,920	New	+$2.86M	0.07%	362